Cargando…
A Mechanistic Pharmacokinetic Model for Liver Transporter Substrates Under Liver Cirrhosis Conditions
Liver cirrhosis is a disease characterized by the loss of functional liver mass. Physiologically based pharmacokinetic (PBPK) modeling was applied to interpret and predict how the interplay among physiological changes in cirrhosis affects pharmacokinetics. However, previous PBPK models under cirrhot...
Autores principales: | Li, R, Barton, HA, Maurer, TS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505828/ https://www.ncbi.nlm.nih.gov/pubmed/26225262 http://dx.doi.org/10.1002/psp4.39 |
Ejemplares similares
-
Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping
Cocktail Differently
por: Duthaler, Urs, et al.
Publicado: (2022) -
Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis
por: Li, Rui, et al.
Publicado: (2017) -
Mechanistic Computational Models of Epithelial Cell Transporters-the Adorned Heroes of Pharmacokinetics
por: King, Jasia, et al.
Publicado: (2021) -
Cirrhosis of the Liver
Publicado: (1904) -
Cirrhosis of the Liver
Publicado: (1905)